Cancer treatment. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cell Line, Tumor Neoplastic Stem Cells Tumor Cells, Cultured Breast HCT116 Cells MCF-7 Cells Prostate HT29 Cells

Organisms4

Mice, Nude Mice, Inbred BALB C Mice, SCID Adenoviridae

Diseases50

Neoplasms Breast Neoplasms Prostatic Neoplasms Lung Neoplasms Ovarian Neoplasms Colonic Neoplasms Neoplasm Metastasis Stomach Neoplasms Pancreatic Neoplasms Neoplasm Invasiveness Colorectal Neoplasms Uterine Cervical Neoplasms Lymphedema Carcinoma Carcinoma, Non-Small-Cell Lung Disease Progression Carcinoma, Squamous Cell Neoplasm Recurrence, Local Genetic Predisposition to Disease Urinary Bladder Neoplasms Rectal Neoplasms Genital Neoplasms, Female Neovascularization, Pathologic Adenocarcinoma Cell Transformation, Neoplastic Head and Neck Neoplasms Fatigue Endometrial Neoplasms Esophageal Neoplasms Bone Neoplasms Neoplasms, Second Primary Liver Neoplasms Neoplasms, Hormone-Dependent Radiation Injuries Gastrointestinal Neoplasms Mammary Neoplasms, Experimental Carcinoma, Small Cell Mouth Neoplasms Neoplasms, Radiation-Induced Neoplasms, Experimental Neoplasms, Glandular and Epithelial Skin Neoplasms Melanoma Pharyngeal Neoplasms Testicular Neoplasms Thyroid Neoplasms Brain Neoplasms Disease Models, Animal Kidney Neoplasms Precancerous Conditions

Chemicals and Drugs55

Antineoplastic Agents Cancer Vaccines Neoplasm Proteins Tumor Markers, Biological Antineoplastic Agents, Phytogenic Receptor, erbB-2 RNA, Small Interfering Tamoxifen Fluorouracil Antineoplastic Agents, Hormonal Receptors, Estrogen RNA, Messenger Cisplatin Tumor Suppressor Protein p53 Prostate-Specific Antigen Paclitaxel DNA, Neoplasm Antibodies, Monoclonal Receptor, Epidermal Growth Factor Antibodies, Monoclonal, Humanized Antigens, Neoplasm Deoxycytidine Anticarcinogenic Agents MicroRNAs Receptors, Progesterone Protein Kinase Inhibitors Antimetabolites, Antineoplastic Tumor Suppressor Proteins Taxoids Antibiotics, Antineoplastic Enzyme Inhibitors Quinazolines Organoplatinum Compounds Receptors, Androgen Androgen Antagonists Prodrugs DNA-Binding Proteins Proto-Oncogene Proteins c-akt Proto-Oncogene Proteins RNA, Neoplasm Transcription Factors Camptothecin Androgens Nuclear Proteins Estrogens Cyclophosphamide BRCA1 Protein Vascular Endothelial Growth Factor A Estrogen Receptor alpha Aromatase Inhibitors Proto-Oncogene Proteins c-bcl-2 Estrogen Receptor Modulators Protein-Serine-Threonine Kinases Plant Extracts Radiation-Sensitizing Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment78

Early Detection of Cancer Radiotherapy Antineoplastic Combined Chemotherapy Protocols Xenograft Model Antitumor Assays Combined Modality Therapy Survival Rate Molecular Targeted Therapy Survival Analysis Clinical Trials as Topic Prognosis Neoplasm Staging Chemotherapy, Adjuvant Follow-Up Studies Retrospective Studies Registries Treatment Outcome Drug Delivery Systems Neoplasm Transplantation Reverse Transcriptase Polymerase Chain Reaction Prospective Studies Gene Expression Profiling Tumor Burden Mastectomy Disease-Free Survival Drug Screening Assays, Antitumor Questionnaires Risk Blotting, Western SEER Program Risk Assessment Individualized Medicine Transplantation, Heterologous Risk Factors Odds Ratio Immunotherapy Genetic Therapy Multivariate Analysis Models, Biological Radiotherapy, Adjuvant Fertility Preservation Kaplan-Meier Estimate Sensitivity and Specificity Palliative Care Mammography Oligonucleotide Array Sequence Analysis Transfection Logistic Models Reproducibility of Results Mammary Neoplasms, Experimental Neoplasms, Experimental Flow Cytometry Predictive Value of Tests Neoplasm Grading Polymerase Chain Reaction Radiotherapy Dosage Prostatectomy Hyperthermia, Induced Clinical Trials, Phase III as Topic Gene Knockdown Techniques Antineoplastic Protocols Photochemotherapy Incidence Drug Administration Schedule Mastectomy, Segmental Immunoenzyme Techniques Immunohistochemistry Cohort Studies Patient Selection Real-Time Polymerase Chain Reaction Drug Design Disease Models, Animal Lymph Node Excision Biopsy Genetic Testing Research Design Tissue Array Analysis Confidence Intervals Inhibitory Concentration 50

Psychiatry and Psychology2

Smoking Decision Making

Phenomena and Processes46

Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Apoptosis Cell Survival Cell Proliferation Genetic Predisposition to Disease Risk Mutation Odds Ratio Signal Transduction Cell Cycle Dose-Response Relationship, Drug Cell Movement Down-Regulation Cell Division DNA Methylation Sensitivity and Specificity Cell Growth Processes RNA Interference Transfection Drug Synergism Time Factors Up-Regulation Genotype Promoter Regions, Genetic Gene Silencing Radiation Tolerance Tumor Microenvironment Genes, BRCA1 Genes, Neoplasm DNA Damage Gene Expression Genes, p53 Genes, Tumor Suppressor Phosphorylation Polymorphism, Genetic Base Sequence Postmenopause Epithelial-Mesenchymal Transition Menopause Phenotype Germ-Line Mutation DNA Repair Inhibitory Concentration 50 Cell Death Epigenesis, Genetic

Disciplines and Occupations6

Medical Oncology Individualized Medicine Immunohistochemistry Drug Design Nanomedicine Research Design

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Technology, Industry, Agriculture2

Nanomedicine Nanoparticles

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Questionnaires SEER Program Incidence Base Sequence Molecular Sequence Data

Named Groups3

Survivors European Continental Ancestry Group African Americans

Health Care37

National Cancer Institute (U.S.)Survival Rate Survival Analysis Clinical Trials as Topic Follow-Up Studies Retrospective Studies Registries Treatment Outcome Prospective Studies American Cancer Society Sperm Banks Disease-Free Survival Questionnaires Risk Age Factors SEER Program Risk Assessment Risk Factors Odds Ratio Multivariate Analysis Kaplan-Meier Estimate Sensitivity and Specificity Palliative Care Radiation Injuries Logistic Models Reproducibility of Results Predictive Value of Tests Clinical Trials, Phase III as Topic Antineoplastic Protocols Incidence Cancer Care Facilities Healthcare Disparities Cohort Studies Patient Selection Patient Participation Genetic Testing Confidence Intervals

Geographicals2

United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Neoplasms Breast Neoplasms Antineoplastic Agents Early Detection of Cancer Prostatic Neoplasms Lung Neoplasms Cell Line, Tumor Ovarian Neoplasms Medical Oncology Colonic Neoplasms Survivors Mice, Nude Neoplasm Metastasis Stomach Neoplasms Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Pancreatic Neoplasms Neoplasm Invasiveness National Cancer Institute (U.S.)Radiotherapy Cancer Vaccines Antineoplastic Combined Chemotherapy Protocols Xenograft Model Antitumor Assays Combined Modality Therapy Survival Rate Molecular Targeted Therapy Neoplasm Proteins Survival Analysis Clinical Trials as Topic Prognosis Colorectal Neoplasms Neoplasm Staging Chemotherapy, Adjuvant United States Apoptosis Uterine Cervical Neoplasms Lymphedema Follow-Up Studies Carcinoma Carcinoma, Non-Small-Cell Lung Disease Progression Retrospective Studies Cell Survival Tumor Markers, Biological Quality of Life Registries Treatment Outcome Drug Delivery Systems Neoplasm Transplantation Carcinoma, Squamous Cell Reverse Transcriptase Polymerase Chain Reaction Cell Proliferation Prospective Studies Neoplasm Recurrence, Local Genetic Predisposition to Disease Urinary Bladder Neoplasms Antineoplastic Agents, Phytogenic Gene Expression Profiling American Cancer Society Receptor, erbB-2 Rectal Neoplasms RNA, Small Interfering Tamoxifen Fluorouracil Sperm Banks Tumor Burden Antineoplastic Agents, Hormonal Mastectomy Disease-Free Survival Receptors, Estrogen Genital Neoplasms, Female Drug Screening Assays, Antitumor Questionnaires Risk Blotting, Western Age Factors Mutation SEER Program Risk Assessment RNA, Messenger Neovascularization, Pathologic Cisplatin Adenocarcinoma Tumor Suppressor Protein p53 Cell Transformation, Neoplastic Individualized Medicine Neoplastic Stem Cells Transplantation, Heterologous Prostate-Specific Antigen Tumor Cells, Cultured Paclitaxel Risk Factors Head and Neck Neoplasms Odds Ratio Immunotherapy Signal Transduction Cell Cycle Fatigue Dose-Response Relationship, Drug Genetic Therapy

No FAQ available that match "cancer treatment"